Exodus Point Capital Management, LP Allogene Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,634,838 shares of ALLO stock, worth $3.06 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,634,838

Previous 291,114 461.58%

Holding current value

$3.06 Million

Previous $678,000 575.22%

% of portfolio

0.03%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.08 - $3.5 $2.79 Million - $4.7 Million	1,343,724 Added 461.58%	1,634,838 $4.58 Million
Q2 2024 Aug 13, 2024	BUY	$2.23 - $4.38 $285,642 - $561,038	128,091 Added 78.57%	291,114 $678,000
Q1 2024 May 14, 2024	BUY	$2.92 - $5.63 $154,856 - $298,575	53,033 Added 48.22%	163,023 $729,000
Q3 2023 Nov 09, 2023	SELL	$3.17 - $5.96 $1.01 Million - $1.89 Million	-317,762 Reduced 74.29%	109,990 $349,000
Q2 2023 Aug 10, 2023	SELL	$4.53 - $6.74 $1.12 Million - $1.67 Million	-247,527 Reduced 36.66%	427,752 $2.13 Million
Q1 2023 May 11, 2023	SELL	$4.92 - $8.21 $2.38 Million - $3.97 Million	-483,422 Reduced 41.72%	675,279 $3.34 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $11.11 $5.26 Million - $10.4 Million	935,460 Added 419.04%	1,158,701 $7.29 Million
Q3 2022 Nov 10, 2022	BUY	$10.32 - $17.28 $1.99 Million - $3.33 Million	192,738 Added 631.87%	223,241 $2.41 Million
Q2 2022 Aug 19, 2022	SELL	$6.78 - $12.28 $127,850 - $231,563	-18,857 Reduced 38.2%	30,503 $348,000
Q1 2022 May 13, 2022	SELL	$7.65 - $15.29 $649,791 - $1.3 Million	-84,940 Reduced 63.25%	49,360 $450,000
Q4 2021 Feb 11, 2022	BUY	$13.13 - $24.52 $1.76 Million - $3.29 Million	134,300 New	134,300 $2 Million
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $262,099 - $344,809	-12,475 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $45,594 - $69,487	1,941 Added 18.43%	12,475 $325,000
Q1 2021 May 17, 2021	BUY	$25.79 - $39.02 $271,671 - $411,036	10,534 New	10,534 $372,000

Others Institutions Holding ALLO

# of Institutions

163

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $269M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Allogene Therapeutics, Inc. Transaction History